1. Thompson AM, Blaser A, Anderson RF, Shinde SS, Franzblau SG, Ma Z, Denny WA, Palmer BD (2009) Synthesis, reduction potential and anti-tubercular activity of ring A/B analogues of the bioreductive drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine. J Med Chem 52(3):637–645
2. Jiwane SK, Singh VK, Namdeo KP, Prajpapti SK (2009) Synthesis of some novel 2,4-thiazolidinedione derivatives and their biological screening as antidiabetic agents. Asian J Chem 21(7):5068–5072
3. Shyam M, Debnath B, Devbhut P (2016) Search for biological active thiazolidinedione: a short review. Indo Am J Pharm Res 6(4):5282–5311
4. Chadha N, Bahia MS, Kaur M, Silakari O (2015) Thiazolidine-2,4-dione derivatives, programmed chemical weapons for key protein targets of various pathological condition. Bioorg Med Chem 23:2953–2974
5. Kumar KS, Reddy BM, Babu VH (2014) Synthesis of some novel 2,4-thiazolidinedione incorporated pyrazole derivatives as anticancer agents. Int J Pharm Sci 6(2):831–834